Chronic GvHD decreases antiviral immune responses in allogeneic BMT
Open Access
- 8 February 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 109 (10), 4548-4556
- https://doi.org/10.1182/blood-2006-04-017442
Abstract
Chronic graft-versus-host disease (cGvHD) is associated with functional immunodeficiency and an increased risk of opportunistic infections in allogeneic bone marrow transplantation (BMT). We used a parent to F1 model of allogeneic BMT to test the hypothesis that cGvHD leads to impaired antigen-specific antiviral immunity and compared BM transplant recipients with cGvHD to control groups of allogeneic BM transplant recipients without GvHD. Mice with and without cGvHD received a nonlethal dose of murine cytomegalovirus (MCMV) +100 days after transplantation. Recipients with cGvHD had more weight loss and higher viral loads in the spleen and liver. MCMV infection led to greater than 25-fold expansion of donor spleen–derived MCMV peptide–specific tetramer-positive CD8+ T cells in blood of transplant recipients with and without cGvHD, but mice with cGvHD had far fewer antigen-specific T cells in peripheral tissues and secondary lymphoid organs. The immunosuppression associated with cGvHD was confirmed by vaccinating transplant recipients with and without cGvHD using a recombinant Listeria expressing MCMV early protein (Lm-MCMV). Secondary adoptive transfer of lymphocytes from donor mice with or without cGvHD into lymphopenic congenic recipients showed that cGvHD impaired tissue-specific homing of antigen-specific T cells. These results indicate that cGvHD causes an intrinsic immunosuppression and explain, in part, the functional immunodeficiency in allogeneic transplant recipients.Keywords
This publication has 36 references indexed in Scilit:
- Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantationTransplantation and Cellular Therapy, 2005
- Alloreactive CD4 T lymphocytes responsible for acute and chronic graft‐versus‐host disease are contained within the CD45RChigh but not the CD45RClow subsetEuropean Journal of Immunology, 2004
- Chronic graft-versus-host disease: clinical manifestation and therapyBone Marrow Transplantation, 2001
- Characterization of CD4– CD8– CD3+ T‐cell receptor‐αβ+ T cells in murine cytomegalovirus infectionImmunology, 2000
- Late Cytomegalovirus Pneumonia in Adult Allogeneic Blood and Marrow Transplant RecipientsClinical Infectious Diseases, 1999
- CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway.The Journal of Experimental Medicine, 1996
- CYTOMEGALOVIRUS-INDUCED CD13-SPECIFIC AUTOIMMUNITY-A POSSIBLE CAUSE OF CHRONIC GRAFT-VERSUS-HOST DISEASE1Transplantation, 1996
- Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.The Journal of Experimental Medicine, 1992
- Indirect induction of radiation lymphomas in mice. Evidence for a novel, transmissible leukemogen.The Journal of Experimental Medicine, 1987
- Risk Factors for Cytomegalovirus Infection after Human Marrow TransplantationThe Journal of Infectious Diseases, 1986